Nature Communications (Jan 2023)

Molecular subtypes of ALS are associated with differences in patient prognosis

  • Jarrett Eshima,
  • Samantha A. O’Connor,
  • Ethan Marschall,
  • NYGC ALS Consortium,
  • Robert Bowser,
  • Christopher L. Plaisier,
  • Barbara S. Smith

DOI
https://doi.org/10.1038/s41467-022-35494-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 18

Abstract

Read online

Variability in ALS disease onset and progression are poorly understood. Our work identifies three distinct molecular states in post-mortem tissue that capture some of the observed differences in patient age of onset and survival.